Cabot (NYSE:CBT) Full Year 2024 Results

Key Financial Results

• Revenue: US$3.99b (up 1.6% from FY 2023).
• Net income: US$374.0m (down 14% from FY 2023).
• Profit margin: 9.4% (down from 11% in FY 2023). The decrease in margin was driven by higher expenses.
• EPS: US$6.79 (down from US$7.79 in FY 2023).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Cabot Earnings Insights

The primary driver behind last 12 months revenue was the Reinforcement Materials segment contributing a total revenue of US$2.61b (65% of total revenue). Notably, cost of sales worth US$3.02b amounted to 76% of total revenue thereby underscoring the impact on earnings. The largest operating expense was General & Administrative costs, amounting to US$284.0m (47% of total expenses). Explore how CBT's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to grow 4.0% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Chemicals industry in the US.

The company's shares are up 1.4% from a week ago.

Risk Analysis

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.